Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate Risk Prostate Cancer”

285 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 285 results

Not applicableEnded earlyNCT00798837
What this trial is testing

Intraprostatic MAXimal Simultaneous Boost

Who this might be right for
Prostate Cancer
British Columbia Cancer Agency 10
Very early researchLooking for participantsNCT06759701
What this trial is testing

Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study

Who this might be right for
DiabetesProstate Cancer
M.D. Anderson Cancer Center 30
Not applicableWithdrawnNCT03935308
What this trial is testing

Phase I Study MR-guided SBRT to PCa

Who this might be right for
Low or Intermediate Risk Prostate Cancer
Henry Ford Health System
Testing effectiveness (Phase 2)Study completedNCT03322020
What this trial is testing

Androgen Deprivation Therapy, External Beam Radiotherapy and Stereotactic Radiosurgery Boost for Prostate Cancer

Who this might be right for
Neoplasm, Prostate
Asan Medical Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT00525720
What this trial is testing

Brachytherapy for Prostatic Carcinoma Patients

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 300
Testing effectiveness (Phase 2)Looking for participantsNCT05361798
What this trial is testing

T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine M9241 in Localized High- and Intermediate-Risk Prostate Cancer Treated With Androgen Deprivation Therapy

Who this might be right for
Cancer Of Prostate
National Cancer Institute (NCI) 65
Not applicableStudy completedNCT00573833
What this trial is testing

Internal Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 23
Early research (Phase 1)Active Not RecruitingNCT02023463
What this trial is testing

Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IIB Prostate Cancer+2 more
Thomas Jefferson University 25
Not applicableActive Not RecruitingNCT01342367
What this trial is testing

Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Chicago 74
Not applicableActive Not RecruitingNCT03383016
What this trial is testing

Diet, Physical Activity and Related Candidate Biomarkers in Relation to Prostate Cancer Risk (BIOCaPPE)

Who this might be right for
EpidemiologyProstate Cancer
CHU de Quebec-Universite Laval 2,053
Not applicableLooking for participantsNCT05668351
What this trial is testing

Stereotactic Ablative Radiation Therapy for Prostate Cancer

Who this might be right for
Prostate Cancer
Medical University of South Carolina 36
Testing effectiveness (Phase 2)UnknownNCT03196388
What this trial is testing

Enzalutamide and External Beam Hypofractionated Radiotherapy For Intermediate Risk Localized Prostate Cancer

Who this might be right for
Prostate Carcinoma
Fundación Canaria de Investigación Sanitaria 70
Testing effectiveness (Phase 2)Looking for participantsNCT06772441
What this trial is testing

Artificial Intelligence Driven Personalisation of Radiotherapy and Concomitant Androgen Deprivation Therapy for Prostate Cancer Patients (the HypoPro Trial)

Who this might be right for
Prostate Cancer
German Oncology Center, Cyprus 30
Not applicableUnknownNCT02594072
What this trial is testing

Androgen Suppression With Stereotactic Body or External Beam Radiation Therapy (ASSERT)

Who this might be right for
Prostate Cancer
University of British Columbia 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT03444844
What this trial is testing

Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer

Who this might be right for
Prostate Cancer RecurrentProstate Cancer
Five Eleven Pharma, Inc. 60
Not applicableNot Yet RecruitingNCT07210502
What this trial is testing

Side Effects of Low Dose Rate Brachytherapy and Ultra-hypofractionated Radiotherapy in Low to Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
Royal Surrey County Hospital NHS Foundation Trust 220
Not applicableEnded earlyNCT01100866
What this trial is testing

Study of POMELLA™ Extract to Treat Prostate Cancer

Who this might be right for
Prostate Cancer
Vancouver Coastal Health 1
Not applicableLooking for participantsNCT04945642
What this trial is testing

High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma

Who this might be right for
Prostate AdenocarcinomaStage IIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage IIC Prostate Cancer AJCC v8+5 more
Jonsson Comprehensive Cancer Center 52
Large-scale testing (Phase 3)Study completedNCT00002723
What this trial is testing

Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 390
Not applicableLooking for participantsNCT03650595
What this trial is testing

MRI Guided Focal Laser Ablation of Prostate Cancer

Who this might be right for
Prostate CancerLow and Intermediate Risk Prostate Cancer
University Health Network, Toronto 102
Load More Results